Company profile for Alpha Tau Medical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Alpha Tau Medical was founded in 2016 and focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Since then, preclinical and clinical trials have found the technology to be effective and safe for various indications and anatomic areas. The findings were p...
Alpha Tau Medical was founded in 2016 and focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Since then, preclinical and clinical trials have found the technology to be effective and safe for various indications and anatomic areas. The findings were published in 16 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
20 Dr. George Wise St., Tel Aviv 6997712
Telephone
Telephone
+1 833-455-3278
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/01/3197086/0/en/Alpha-Tau-to-Participate-in-December-Investor-Conferences.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/20/3192378/0/en/Alpha-Tau-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/11/3185416/0/en/Alpha-Tau-to-Participate-at-Jefferies-Global-Healthcare-Conference-in-London.html

GLOBENEWSWIRE
11 Nov 2025

https://www.globenewswire.com/news-release/2025/10/21/3170190/0/en/Alpha-Tau-Announces-Receipt-of-Radioactive-Material-License-for-its-New-Hampshire-Manufacturing-Facility-Advancing-Towards-Commercial-Readiness.html

GLOBENEWSWIRE
21 Oct 2025

https://www.globenewswire.com/news-release/2025/09/02/3142676/0/en/Alpha-Tau-Successfully-Treats-First-Patient-in-its-U-S-Multi-Center-Pancreatic-Cancer-Clinical-Trial.html

GLOBENEWSWIRE
02 Sep 2025

https://www.globenewswire.com/news-release/2025/08/27/3140010/0/en/Alpha-Tau-to-Participate-in-Five-September-Investor-Conferences.html

GLOBENEWSWIRE
27 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty